Homeostasis is a key feature of the cellular lifespan. Its maintenance influences the rate of ageing and it is determined by several factors, including efficient proteolysis. The proteasome is the major cellular proteolytic machinery responsible for the degradation of both normal and damaged proteins. Alterations of proteasome function have been recorded in various biological phenomena including ageing and replicative senescence. Proteasome activities and function are decreased upon replicative senescence, whereas proteasome activation confers enhanced survival against oxidative stress, lifespan extension and maintenance of the young morphology for longer in human primary fibroblasts. Several natural compounds possess anti-ageing/anti-oxidant properties. In this study, we have identified quercetin (QUER) and its derivative, namely quercetin caprylate (QU-CAP) as a proteasome activator with antioxidant properties that consequently influence cellular lifespan, survival and viability of HFL-1 primary human fibroblasts. Moreover, when these compounds are supplemented to already senescent fibroblasts, a rejuvenating effect is observed. Finally, we show that these compounds promote physiological alterations when applied to cells (i.e. whitening effect). In summary, these data demonstrate the existence of naturally occurring anti-ageing products that can be effectively used through topical application.
Introduction
Free radicals are reactive molecules with one or more unpaired electron(s). Living organisms are constantly exposed to them as a consequence of aerobic life and physiology. In normal situations, the endogenous antioxidant network that comprises several primary and secondary antioxidant mechanisms provides sufficient protection against reactive species like ROS and RNS (Sen, 1995) . However upon different situations an imbalance between oxidative load and anti-oxidation might appear leading to increased oxidative stress. Elevated levels of oxidative stress are related to various phenomena including ageing .
Ageing is a natural, inevitable phenomenon that can be studied in vivo and in vitro. In vitro normal human fibroblasts undergo a limited number of divisions in culture and progressively they reach a state of irreversible growth arrest, a process termed as replicative senescence. Senescence is attributed to a combination of genetic and environmental factors (Petropoulou et al., 2000) .
Senescent fibroblasts are viable and fully functional with several alterations of morphological and biochemical characteristics as compared to their young / proliferating counterparts (Collado et al., 2007) . Several cellular mechanisms malfunction upon senescence with the main secondary antioxidant mechanism, namely the proteasome, included . The proteasome is the major cellular non-lysosomal threonine protease, implicated in the removal of normal as well as abnormal, denatured or otherwise damaged proteins (Navon and Ciechanover, 2009 ). The core particle, namely the 20S proteasome, is a barrel-shaped complex made of 28 subunits, 7 different α-and 7 different β-subunits, arranged as α1-7 β1-7 β1-7 α1-7 structure. The β5, β1 and β2 subunits are the catalytic centers of chymotrypsin-like (CT-L), caspase-like/PGPH (peptidylglutamyl-peptide hydrolyzing) and trypsin like (T-L) activities, respectively, cleaving peptide bonds after hydrophobic, acidic and basic residues respectively (Tanaka, 1998) . The 20S proteasome is also central to the ATP/ubiquitin dependent intracellular protein degradation pathway where it represents the proteolytic core of the 26S complex (Glickman and Ciechanover, 2002 ).
We and others have reported loss of proteasome function upon ageing of several human tissues as well as in senescent primary cultures. We have shown a reduction of proteasome activities and content upon replicative senescence of human embryonic fibroblast cultures with an acceleration of senescence upon proteasome inhibition (Chondrogianni et al., 2008, Chondrogianni and Gonos, 2004,) .
Importantly, upon proteasome activation either through genetic means or through natural means (Katsiki et al., 2007) , a delay of senescence by approximately 15% is observed.
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The biological process of ageing can be positively influenced by few environmental factors, such as natural antioxidants. Vitamin E (Packer et al., 1974) , kinetin Clark, 1994), carnosine (McFarland and Holliday, 1994) and garlic (Svendsen et al., 1994) are few examples of natural compounds that have been shown to exert a pro-longevity effect on human primary cultures. More importantly, natural substances that possess proteasome activating properties like oleuropein (Katsiki et al., 2007) have been also shown to promote lifespan extension. Given these findings, we sought to investigate the role of QUER, a potent, natural anti-oxidant, on survival and lifespan of human fibroblasts along with its possible effects on the main secondary antioxidant mechanism, the proteasome.
Materials and Methods
Reagents and antibodies
QUER was purchased from Biospectrum, QU-CAP and caprilic/capric triglycerides (CAP) were obtained from BASF and dimethyl sulfoxide (DMSO) was obtained from Sigma. LLVY-AMC, MG132, as well as primary proteasomal antibodies against α 7 (PW8110; 30 kDa) and β 5 (PW8895; 23 kDa) subunits were purchased from BIOMOL. Primary antibodies against GAPDH (sc25778; 37 kDa) and secondary antibodies were purchased from Santa Cruz Biotechnology. Primary antibody against tyrosinase (#MS-800-P0, 70-80 kDa) was obtained from Thermo Scientific.
Cell lines and culture conditions
HFL-1 human embryonic fibroblasts (obtained by the European Collection of Cell Cultures) and mouse melanocytes (B10F16 cell line) were maintained in Dulbecco's modified Eagle's medium (DMEΜ; Invitrogen) supplemented with 10% foetal bovine serum (v/v; Invitrogen), 2 mM glutamine, and 1% non-essential amino-acids. Cells were subcultured at 37 ο C, 5% CO 2 and 95% humidity, were fed approximately 16 h prior to each assay and cell number was determined in duplicates using a Coulter Z 2 counter (Beckman Coulter). HFL-1 cells were subcultured when they reached confluence at a split ratio 1:2 until they entered to senescence.
Proteasome peptidase assays
HFL-1 or B10F16 cells were seeded in petri dishes (5x10 5 cells) and the following day they were treated with 2 μg/ml (for HFL-1 cells) or 5 μg/ml (for B10F16 cells) QUER, 0.5, 2 and 5 μg/ml (for HFL-1 cells) or 5 and 10 μg/ml (for B10F16 cells) QU-CAP or the diluents (0.1% DMSO or 0.1% CAP) for 24h. Proteins were then extracted and CT-L proteasome activity was assayed in crude extracts with the hydrolysis of the LLVY-AMC fluorogenic peptide at 37°C for 30 min, as 4 A C C E P T E D M A N U S C R I P T
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described previously . Proteasome activity was determined as the difference between the total activity of crude extracts and the remaining activity in the presence of 20 μM MG132. Fluorescence was measured using a VersaFluor TM fluorescence spectrophotometer (BioRad). Protein concentrations were determined using the Bradford method with bovine serum albumin (BSA) as standard.
Immunoblot analysis and detection of oxidized proteins
Cells were harvested at indicated time points, lysed in reducing Laemmli buffer and proteins were fractionated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) according to standard procedures (Harlow and Lane, 1999 
Measurement of reactive oxygen species
2', 7'-dichlorodihydrofluorescein diacetate H 2 DCFDA (Molecular Probes, Invitrogen) was used for the detection of reactive oxygen species (ROS). HFL-1 cells treated with 2 μg/ml QUER, 0.5, 2 and 5 μg/ml QU-CAP or the diluents (0.1% DMSO or 0.1% CAP) for 24 h, were resuspended in PBS ± the dye at a final concentration of 10 μM (loading buffer) and incubated at 37°C for 30 min. The loading buffer was then removed; cells were resuspended in prewarmed complete medium and incubated at 37°C for 5 min. The absorption and the emission of the oxidation product were measured at 493 and 520 nm respectively. Each sample was measured in triplicates.
In replica cultures, cells were additionally incubated with 300 μM H 2 O 2 in the presence or absence of the substances for 2.5 h and cells were then collected for detection of ROS.
Continuous cell treatment with QUER or QU-CAP
Five x 10 4 young HFL-1 cells were treated with 2 μg/ml QUER, 0.5, 2 and 5 μg/ml QU-CAP or the diluents (0.1% DMSO or 0.1% CAP) every day until they entered senescence. Upon 90% confluence, cell number was determined in triplicates using a Coulter Z 2 counter and the performed population doublings were calculated using the formula: log (N f / N 0 ) / log 2, where N f is the number of cells that were measured when each culture reached confluence and N 0 5 A C C E P T E D M A N U S C R I P T
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represents the number of cells that was initially seeded. Photographs of the cells maintained in cell culture and treated with the substances for the same time period were taken. For rejuvenation assay of middle-aged (cpd 59) or terminally senescent cells (cpd 65), HFL-1 fibroblasts were subcultured when they reached confluence at a split ratio 1:2 until they entered to the requested cpd in the absence of the substances and were then subjected to treatment with 2 μg/ml QUER, 0.5, 2 and 5 μg/ml QU-CAP or the diluents (0.1% DMSO or 0.1% CAP) for 5 days (for middleaged cells) and for 2 weeks (for terminally senescent cells) before being photographed, assayed for β-galactosidase activity or counted using a Coulter Z2 counter (Coulter Corporation). The cells were replenished with fresh media supplemented with the substances or the diluents every 24 h.
β -Galactosidase Staining
Staining for β-galactosidase activity was performed as described previously (Dimri et al., 1995) .
Briefly, 10 5 cells were seeded in 6-well plates. After 24 h cells were washed with PBS, fixed in 0.2% glutaraldehyde and 2% formaldehyde for 5 min, washed again with PBS and finally stained at 37 °C for 24 h in the absence of CO 2 , in staining solution (150 mM NaCl, 2 mM MgCl 2 , 5 mM K 3 Fe(CN) 6 , 40 mM citric acid, and 12 mM sodium phosphate, pH 6.0) containing 1 mg/ml 5-bromo-4-chloro-3-indolyl-β-D-galactoside.
Survival assays
Cell survival was monitored by counting the number of cells following treatment with 300 μM H 2 O 2 for 2.5 h. Briefly, 4 x 10 5 HFL-1 cells were plated in petri dishes and 24 h later they were treated with 2 μg/ml QUER, 0.5, 2 and 5 μg/ml QU-CAP or the diluents (0.1% DMSO or 0.1% CAP) for additional 24 h, followed by incubation with 300 μM hydrogen peroxide (H 2 O 2 ) for 2.5
h. Cells were left to recover for 5 days and then their numbers were scored. Cell number was determined in triplicates using a Coulter Z 2 counter.
Whitening assay 10 5 B10F16 melanocytes were seeded in petri dishes and the following day they were treated with 5 μg/ml QUER, 5 and 10 μg/ml QU-CAP or the diluents (0.1% DMSO or 0.1% CAP) for 72 h.
The media were replenished every 24 h. Cells were then collected and pelleted and the cell pellet was photographed and quantified. The same cell pellet was then used for protein extraction and immunoblot analysis as described above.
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Statistical analysis
Statistics were performed by using Microsoft Excel software. Statistical significance was evaluated using the one-way analysis of variance (ANOVA). Results at p < 0.05 or p < 0.01 are denoted in graphs by a single (*) or double (**) asterisk, respectively. All values were reported as mean of three independent experiments ± standard deviation, unless otherwise indicated.
Results
QUER and QU-CAP possess anti-ageing and rejuvenating properties.
Initially, we aimed to reveal potential anti-ageing properties of QUER ( Figure Table 1 recapitulates the percentage of β-galactosidase positive cells following constant treatment with QUER and QU-CAP for 55 days.
We were then asked whether the positive effects of QUER and QU-CAP also apply on middleaged and terminally senescent cells. Therefore, middle-aged cells (~1 population doubling per 1 week) and terminally senescent cells (0 population doublings per 2 weeks) were treated with 2 μg/ml QUER, 0.5, 2 and 5 μg/ml QU-CAP or the diluents (0.1% DMSO or 0.1% CAP) for 5 consecutive days (for middle-aged cells) and for 2 weeks (for terminally senescent cells) and they were then counted. As shown in 
Cytoprotective effects of QUER and QU-CAP.
Next, we investigated the QUER and QU-CAP effects on cellular survival following oxidative stress and consequently on the intracellular ROS levels and the oxidative protein load. As shown in Fig. 4 , cells that were treated with QUER or QU-CAP exhibited higher survival rates ranging from 5.4% to 7.5% as compared to the cells that were treated with the diluents. Additionally, cells that were treated with QUER or QU-CAP and were then subjected to oxidative stress exhibited a higher survival rate reaching to 14.5% as compared to the survival rate of the relative control 
Proteasome activation by QUER and QU-CAP.
As QUER and QU-CAP have been related to mechanisms against oxidative stress, we then addressed the question whether these substances have an effect on the main secondary antioxidant mechanism of the cell, the proteasome. Young HFL-1 cells were treated with 2 μg/ml QUER, 0.5, 2 and 5 μg/ml QU-CAP or the diluents (0.1% DMSO or 0.1% CAP) for 24 h and the CT-L proteasome activity was measured. As shown in Fig. 6A , the activity was significantly induced following cell treatment with either of the substances. CT-L activity was increased from ~1.5 (for QU-CAP) to ~2.4 fold (for QUER). Moreover we have also detected enhanced protein expression levels of representative proteasome subunits in the same cells and experimental conditions (Fig. 6B) , thus further verifying proteasome activation by QUER and QU-CAP.
Whitening properties of QUER and QU-CAP.
We were then asked whether this activated proteasomal pathway has physiological effects on cellular characteristics. Skin pigmentation is a characteristic that accompanies skin ageing (Ortonne, 2001) . Tyrosinase, the main metalloglycoprotein that catalyzes several steps in the melanin pigment biosynthetic pathway that is mainly responsible for the age spots, has been shown to be a proteasome substrate (Ando et al., 2004) , and proteasome-mediated tyrosinase degradation has been shown to promote skin de-pigmentation (Ando et al., 2004 (Ando et al., , 2009 ).
Moreover, increasing number of studies is dealing with the identification of natural compounds 8
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that may act as de-pigmenting agents (Smit et al., 2009) . Consequently, the whitening properties of our compounds were also tested. Initially, we tested whether QUER and QU-CAP exert proteasome activating effects on melanocytes. Therefore, mouse melanocytes (B10F16 cell line)
were treated with 5 μg/ml QUER or 5 and 10 μg/ml QU-CAP (we note that for this cell line and the relative assays a higher concentration of the compounds was necessary) for 24 h. As shown in Fig. 7A , CT-L activity is stimulated in melanocytes by both QUER and QU-CAP. Mouse melanocytes were then constantly treated with 5 μg/ml QUER or 5 and 10 μg/ml QU-CAP for 72 h and they were then collected, pelleted and photographed. As shown in Fig. 7B , treatment with QUER and QU-CAP revealed whitening potential. This was further verified when the protein expression levels of tyrosinase of treated cells were revealed. In the presence of QUER and QU-CAP reduced levels of tyrosinase were detected coinciding with the observed whitening effect (Fig. 7C ).
Discussion
In this study, we have identified QUER and its derivative, namely QU-CAP as a potent proteasome activator with antioxidant properties that consequently influence cellular lifespan, survival and viability. Moreover, we reveal a rejuvenating effect of these compounds on middleaged and terminally senescent primary fibroblasts. Although the anti-oxidant properties of QUER are already known, this is the first demonstration of its anti-ageing and rejuvenating effects in in vitro studies that link it with the proteasome and its activation.
Flavonoids are a group of antioxidants that are good candidates for antioxidant therapy. They constitute a class of naturally occurring polyphenolic compounds, ubiquitously present in photosynthesizing cells (Saito, 1974) . They are present in fruits, vegetables, nuts and plantderived beverages such as tea and wine (Kuhnau, 1976 
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QUER has been shown to be a powerful in vitro anti-oxidant (Hanasaki et al., 1994 , van Acker et al., 1995 . It is a potent scavenger of ROS and RNS, including O 2 •-, NO and ONOO - (Boots et al., 2008) . This enhanced capacity is related to the optimal configuration of two pharmacophores within the molecule (Heijnen et al., 2002) . Furthermore, various in vitro studies have shown that QUER possesses a wide range of pharmacologic and health promoting properties including antimicrobial (Cushnie and Lamb, 2005, Sen et al., 2007) , anti-inflammatory (Orsolic et al., 2004 , Read, 1995 and anti-tumorogenic/anti-proliferative (Gulati et al., 2006 , Kuo, 1996 More in vivo studies regarding QUER supplementation have been performed but lack of positive effects was reported (Conquer et al., 1998 , Wilms et al., 2005 . This however could be explained by the fact that the latter studies involved study of healthy volunteers and not subjects under Nevertheless, there are reports of other groups in the mouse model where a protective effect of topical formulations containing QUER against UVB-induced oxidative stress in hairless mice was reported (Casagrande et al., 2006) . The possible explanation for the observed positive results could be that our skin is constantly under stress due to UV/light exposure.
Given the anti-oxidant properties of QUER and the link between ageing and oxidative stress , the QUER-mediated protection against ageing has been also studied.
QUER has been previously shown to exert protective effects on ageing of specific tissues and functions in various mouse and cellular models. For example, upon supplementation with QUER,
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enhancement of exploratory behavior, spatial learning and memory has been revealed in aged mice (Liu et al., 2006) , a protective effect on immune cell functions has been shown in prematurely senescent mice (Alvarez et al., 2006) , whereas a reversal of ageing and chronic ethanol-induced cognitive dysfunction (Singh et al., 2003) and a protective effect in primary neurons against Abeta(1-42) (Ansari et al., 2009 ) have been also reported. Additionally, QUER has been shown to increase oxidative stress resistance and longevity in Saccharomyces cerevisiae (Belinha et al., 2007) and to extend lifespan in C. elegans (Kampkötter et al., 2007 , Pietsch et al., 2009 , Saul et al., 2008 . We are the first to present anti-ageing affects of QUER in human primary fibroblasts along with the rejuvenating effects on senescent cells.
The proteasome represents the main secondary antioxidant mechanism (Davies, 1986 , Grune et al., 1997 ) that becomes activated upon oxidative challenge. It is responsible for the cellular clearance from damaged and oxidized proteins that may cause deleterious side effects upon lack of proteolysis and aggregation. Given that we have already shown that the proteasome can be activated either through genetic means or through natural means (Katsiki et al., 2007) endowing the cells with an enhanced survival capacity against oxidative stress and an extended lifespan, we have examined whether QUER as a potent antioxidant agent may stimulate the proteasome function. We show that CT-L proteasome activity and content are induced upon QUER treatment in HFL-1 human primary cells. QUER is a known enhancer of Nrf2 transcription factor (Tanigawa et al., 2007) and Nrf2 has been shown to regulate genes forming the 26S proteasome complex (Kwak et al., 2003) . Therefore, the QUER-mediated proteasome activation that we report could be mediated via the Nrf2 pathway. This could additionally explain the increased survival ability of cells following treatment with QUER and its derivatives since activation of Nrf2 pathway enhances the cellular antioxidant capacity through the transcription of a panel of antioxidant and anti-inflammatory genes (Kensler et al., 2007 , Zhang, 2006 . It is also worth noting that previous reports have shown inhibitory effects of QUER on CT-L proteasome activity but these studies were performed either in cell-free systems or in tumor cells and the used concentrations were constantly over 25μΜ (Chen et al., 2005) in contrast to our effective concentration that reaches 6.6 μΜ (2 μg/ml). Moreover, the same group reports the selective inhibition of proteasome activity in tumor cells but not in non-transformed cells concluding that specific flavonoids might have the potential to be developed into cancerpreventative agents that function through the mechanism of proteasome inhibition selectively in cancer over normal cells. Finally, the positive effect of QUER and QU-CAP on pigmentation that we show may be at least partially linked to proteasome activation given that a link between the ubiquitin-proteasome system and the regulation of skin pigmentation has already been revealed in
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melanocytes (Ando et al., 2004 (Ando et al., , 2009 ). In conclusion, it is worth noting that given the multiple pathways that the proteasome is implicated along with the various functions that an anti-oxidant can affect, we have to keep in mind that proteasome stimulation might represent just one possible explanation among others for the reported anti-ageing and rejuvenating effects of QUER and QU-CAP. We believe that it is the combination of pure anti-oxidant properties with the proteasome activating properties of QUER and QU-CAP that lead to the described protective effects.
Ageing is an unavoidable biological phenomenon influenced by both genetic and environmental factors . Many attempts are made in the marathon towards healthy ageing and/or longevity. Although research has shown that genetic manipulations are usually more potent with stronger effects, they provide minimal help for future anti-ageing intervention due to obvious bioethical and practical restrains. In this regard, natural compounds exerting protective effects against diseases but also normally occurring situations like failure of homeostasis and ageing are the bet of nutraceutical but also cosmeceutical fields. QUER and its derivatives represent strong players in the anti-oxidation battle with expansion to various oxidation-related situations like diseases and ageing of various tissues, including skin while their reported rejuvenating effects place them among the runner-ups in the quest for natural anti-ageing products.
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